3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
18
Carcinoma, Hepatocellular
9
Neoplasms
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Nasopharyngeal Carcinoma
6
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Recurrence
4
Esophageal Squamous Cell Carcinoma
4
Colonic Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Solid Cancers
2
Small Cell Lung Carcinoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Gastric / Gastroesophageal Junction Adenocarcinoma
2
EBV-associated Tumors
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Bites and Stings
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Nivolumab
3
Biopsy
2
pembrolizumab
1
dehydroftorafur
1
X-Rays
1
Watchful Waiting
1
Taxes
1
Sigmoidoscopy
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Proctoscopy
1
Phantoms, Imaging
1
Paclitaxel
1
Observation
1
Mitozytrex
1
Mitomycin
1
Ipilimumab
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Colonoscopy
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anal Canal Carcinoma
×
Immune Checkpoint Inhibitors
×
1 year
×
Clear all
No trials found.